Rating Rationale
December 19, 2022 | Mumbai
UPL Limited
Ratings reaffirmed at 'CRISIL AA+/Stable/CRISIL A1+'
 
Rating Action
Total Bank Loan Facilities RatedRs.6400 Crore
Long Term RatingCRISIL AA+/Stable (Reaffirmed)
Short Term RatingCRISIL A1+ (Reaffirmed)
 
Rs.1800 Crore Commercial PaperCRISIL A1+ (Reaffirmed)
Note: None of the Directors on CRISIL Ratings Limited’s Board are members of rating committee and thus do not participate in discussion or assignment of any ratings. The Board of Directors also does not discuss any ratings at its meetings.
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings has reaffirmed its ‘CRISIL AA+/Stable/CRISIL A1+’ ratings on the bank facilities and commercial paper of UPL Limited (UPL).

 

The ratings continue to reflect UPL’s strong business risk profile supported by a strong market position, geographical diversification in revenue, and healthy profitability backed by sound operating efficiencies, leading to sizeable annual cash generation. Financial risk profile is expected to remain adequate and debt metrics improve gradually over the medium term. These strengths are partially offset by large working capital requirement and susceptibility to risks inherent in the agrochemical sector.

 

UPL registered a strong operating performance in fiscal 2022, supported by healthy growth across geographies; revenue grew by a healthy 21% year-on-year. Operating margins was maintained at 22% in fiscal 2022, despite the increase in raw material costs and commodity inflation, driven by favorable product mix and cost optimization measures. Gross debt increased moderately to ~Rs 26700 crore as on March 31, 2022 from Rs 24140 crore as on March 31, 2021, primarily on account of increase in working capital requirements in line with higher revenues especially from Brazil where the credit period is higher, as well as due to inflationary impact on raw material stock. However, due to materially higher cash surpluses of almost Rs.6960 crores,  net debt was flattish at Rs.20,301 crore at March 31, 2022 (almost similar to previous fiscal).With increase in operating profits, the ratio of net debt to EBITDA (earnings before interest, depreciation, interest and tax) however reduced to 2.15 times in fiscal 2022 compared to 2.46 times in fiscal 2021.

 

UPL continued to report healthy growth in revenues and profits in the first half of fiscal 2023 as well. The company’s revenue grew by over 22% year-on-year on the back of sustained demand for their products and global economic recovery after the pandemic till date. Business in all the regions have witnessed reasonable growth except for Europe where the revenues remained flat. Operating margins improved marginally to 22.3% in the first half of fiscal 2023 (22% in corresponding period of last f.iscal). However, net debt stood at Rs. 28,512 crore as on September 30, 2022, an increase of over Rs. 8000 crores from March 31,2022, mainly on the account of higher working capital needs to secure raw material due to geo-political issues and lower factoring of receivables in the LATAM due to higher cost.

 

In October 2022, the company’s management announced realignment of their existing business into 4 pure play business platforms and investments from private equity investors Abu Dhabi Investment Authority (ADIA), Brookfield, KKR and TPG Capital Asia (TPG) into the realigned businesses. Company has realigned their existing businesses into (1) India agrochemical business (UPL Sustainable Agri Solutions Ltd ,UPL SAS), (2)Global Corp protection business (UPL Ltd, Cayman), (3) global seed business (Advanta Enterprises Ltd) and (4) manufacturing, speciality chemicals and other global businesses. This was done to unlock value and increase focus on each of the segment  and the corporate realignment was approved by the shareholders recently. CRISIL Ratings will continue to assess UPL Ltd on a consolidated basis. 

 

As part of the above corporate realignment strategy, a net equity infusion of USD 259 mn is expected from the following transactions:

                   equity infusion of USD 300 mn (~Rs.2460 cr) from KKR for an equity stake of 13.33% in Advanta Enterprises

                   equity infusion of USD 200 mn (~Rs.1580 cr) from Abu Dhabi Investment Authority (ADIA), TPG and Brookfield for an equity stake of 9.09% in UPL SAS Limited.

                   Payout of USD 241 Mn shall be made to ADIA/TPG for their holding of 22.2% to exit the International Seeds and other global business.

 

CRISIL Ratings is of the view that the expected cash flow from the stake sale, moderation in inventory levels and hence working capital borrowings, along with expected increase in factoring in the second half of fiscal 2023 will help UPL reduce net debt gradually. CRISIL Ratings expects UPL’s net debt/EBITDA at ~2 times by March 2023.

 

Supported by the company’s healthy business risk profile, strong R&D pipeline, and healthy presence in large markets like Latin America (LATAM), revenue growth should remain in high-single digits over the medium term. Further, investments in digital platform (Nurture farm)  are also expected to support revenue growth. Operating profitability should benefit from rising share of higher margin bio-solutions as well as improving cost efficiencies, and remain at 20-22%.

Analytical Approach

To arrive at its ratings, CRISIL Ratings has combined the business and financial risk profiles of UPL Ltd and its subsidiaries, collectively known as UPL. This is because all these companies are under a common management and have close operational linkages and fungible cash flows. CRISIL Ratings follows a moderate integration approach for investment in associates and joint ventures in which UPL has significant influence but not a controlling interest—specifically, CRISIL Ratings factors in UPL's share in the profit of these entities and any incremental investment required.

 

Goodwill on the acquisition of Arysta is being amortized over a period of 15 years commencing from fiscal 2019. Consequently, reported PAT, net worth, and ratio computations are adjusted.

 

USD denominated Perpetual Subordinated Capital Securities (Bonds) of USD 400 Million (interest coupon rate of 5.25% p.a.) raised by UPL Corporation Ltd (subsidiary of UPL) has been treated as 50% debt and 50% equity.

 

Non-recourse factoring of receivables has not been treated as debt

 

Please refer Annexure - List of entities consolidated, which captures the list of entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description

Strengths:

Large scale with diverse geographical presence and wide product portfolio: UPL is among the top 5 players in the global agrochemicals industry. Revenue base is well diversified, with ~70% generated from LATAM, Europe, and the North America in fiscal 2022. Wider geographical reach reduces susceptibility to cyclicality in demand from any one region. The company is also present across the crop lifecycle, from seeds, seed-treatment products, pre- and post-harvest products, to storage-treatment products. Business risk profile remains healthy, aided by a portfolio of 13,000+ registrations, over 200 active ingredients, and 1,023 patents. The group is present in 138 countries with 48 manufacturing locations, employing more than 10,400 people across the globe.

 

Sound operating efficiencies, supporting healthy profitability: Backward integration and supply-chain management have strengthened operating efficiencies. As a sizeable portion of raw material and power requirement is met in-house, the group is assured a steady supply, with lesser price volatility. Flexible and multi-product manufacturing facilities, and the robust supply chain and distribution network have kept operating margin healthy. CRISIL Ratings expects UPL will continue to maintain healthy operating profitability of over 20% over the medium term, supported by its strong efficiencies.

 

Adequate financial risk profile: The acquisition of Arysta in fiscal 2019 was funded through substantial debt (~USD 3 billion), which resulted in moderation in debt metrics. However, the company has been reducing its debt until fiscal 2021, which led to gradual improvement in financial risk profile. For instance, in fiscal 2021, UPL reduced its gross debt by ~Rs. 4800 crore in fiscal 2021 supported by strong operational cash generation and partial pre-payment of debt, but in fiscal 2022, debt levels increased by ~Rs 2500 crore mainly on account of increased working capital requirements. UPL’s financial risk profile is however supported by sizeable adjusted net worth of Rs 26,630 crore as on March 31, 2022.

 

UPL’s management is committed to reducing debt levels further over the medium term, including through streamlining of inventory, recent receipt of equity proceeds and enhancing factoring of receivables. Along with strong operating performance and continuing healthy cash flow generating ability, net debt to EBITDA is expected to reduce to ~2  times in fiscal 2023 (from 2.15 times in fiscal 2022, and 2.46 times in fiscal 2021). Any sizeable debt funded acquisition or continuing high debt levels will remain a credit monitorable.

 

UPL Corp's minority investors, ADIA and TPG, each with ~11% stake, and who had invested in UPL Corp to support the acquisition of Arysta have the option to sell their stakes, to which UPL has right of first refusal. These stakes have now moved to UPL Ltd, Cayman under the recent restructuring. While the stake sale is unlikely in next 1-2 years, any material debt addition by UPL to buy back these stakes in UPL Ltd, Cayman from these investors, and consequent increase in its leverage will also be a key monitorable.

 

Weaknesses:

Large working capital requirement: The crop protection business is seasonal in nature. Sales occur at the start of the season, but payment is realized post-harvest, resulting in long receivable cycle. Furthermore, as goods are manufactured at one place and distributed to other locations, sizeable stock of finished goods needs to be maintained. The large credit required by customers in key LATAM markets also leads to a stretch in working capital cycle. However, the group will contain the exposure to markets with long credit cycle to less than one-third of its revenue and utilize securitization benefits (without recourse) wherever available, thereby mitigating the impact of a stretched cycle on the overall credit profile.

 

Susceptibility to risks inherent in the agrochemicals sector: The crop-protection sector remains susceptible to specific and separate registration processes in different countries, and various environmental rules and regulations. Change in regulatory requirements, such as export and import policies and environmental and safety requirements in countries where the company has significant exposure, could weaken growth prospects. Furthermore, the sector is highly dependent on monsoon and level of farm income. Hence, timing and distribution of rainfall during a year plays a crucial role. This is somewhat mitigated by the geographically diverse base of UPL.

Liquidity: Strong

Cash and cash equivalents stood at Rs 4,038 crores as on September 30, 2022. Utilization of domestic fund-based working capital limits was moderate at about 53% (of drawing power) for the 12 months ending October 2022. The company is expected to reduce its debt over the medium term, supported by healthy cash generation (in excess of Rs. 6000 crore annually), notwithstanding large working capital requirements. Annual capital expenditure (capex) of about Rs 2,500 crore is also expected to be funded largely from internal accruals.

 

The company had modest annual repayments of Rs 144 crore during fiscal 2023, which was serviced from internal accruals. Company had substantial repayment commitments during Q4 FY24 to the tune of Rs.12500 crores which the company was able to refinance, post which the company currently has a moderate repayment of Rs 1500 crores until fiscal 2025 and has a sizeable repayment of Rs.7800 crores during fiscal 2026. Given that the company has been able to arrange large funding in timely manner in the past, CRISIL Ratings expects the company will also be able to refinance required portion of their obligations in fiscal 2026.

 

Environment, social and governance (ESG) Profile:

CRISIL Ratings believes that UPL’s ESG profile supports its already strong credit risk profile.

 

The agro-chemical sector has a high impact on the environment because of the high greenhouse gas (GHG) emissions, water use and high hazardous waste generation by its core operations. The sector has a social impact because of its large workforce, impact on health and wellbeing of its workers and local community on account of its nature of operations.

 

UPL Ltd has undertaken various initiatives and efforts towards mitigating its environmental and social impact and strengthening its ESG profile. 

 

Key ESG highlights:

  • During FY21, UPL reduced 15% carbon emission intensity, 22% water consumption intensity and 31% waste disposal intensity. UPL is also the first agrochemical company to make technical manufacturing facility Zero Liquid Discharge (ZLD).
  • Consistent increase in using renewable power over the years with 19% of electricity from renewable sources for two of its largest manufacturing plants during fiscal 2021
  • Company has been ranked as no 1 global agrochemical company by Sustainalytics in ESG risk rating and also included in the Dow Jones Sustainability index 2021.
  • UPL has also raised sustainability linked loan of $1.45 billion in fiscal 2022.
  • UPL’s governance structure is characterized by majority of its board comprising independent directors, and extensive disclosures.
  • The company has been in the news for plant accidents, chemical spills, whistleblower complaint and change in auditor of a subsidiary. 

There is growing importance of ESG among investors and lenders. UPL’s commitment to ESG principles will play a key role in enhancing stakeholder confidence, given its high share of market borrowings in its overall debt and access to both domestic and foreign capital markets.

Outlook: Stable

CRISIL Ratings believes the UPL group’s business risk profile has improved significantly by the acquisition of Arysta, propelling it to the position of the fifth-largest player in the global agrochemical space and the fourth-largest seed manufacturer. Better scale and business synergies, as well as favourable product mix help sustain operating profitability at over 20-22% over the medium term, benefitting cash generation. This along with progressive debt reduction, will help keep debt metrics at comfortable levels over the medium term.

Rating Sensitivity factors

Upward Factors

  • Better than expected growth in revenues, with operating profitability in excess of 21-22%, ensuring strong cash generation
  • Net Debt/EBITDA remaining below 1-1.25 time on a sustained basis, due to better than anticipated cash generation and lower debt levels due to prudent working capital management or equity infusion.

 

Downward Factors

  • Sharp decline in revenue growth and fall in operating profitability to below 16-17%, materially impacting cash generation
  • Increase in net debt/EBITDA levels beyond 2.5 times on a sustained basis, due to lower cash generation or higher debt levels, due to more than anticipated capex, material acquisitions and elongation in working capital cycle, or to increase stake in UPL Ltd, Cayman.

About the Company

Incorporated in 1969 and promoted by Mr Rajnikant Shroff, UPL manufactures, markets, and distributes crop protection products, intermediates, speciality chemicals, and other industrial chemicals; and undertakes research in these segments. Over time, UPL has made several acquisitions and entered into strategic alliances to diversify product profile and increase geographical reach. The group now includes over 200 entities. Apart from UPL, the other key operating companies in the group are UPL NA Inc (US), UPL Europe Ltd (UK), UPL Agro SA DE CV (Mexico), UPL Argentina SA (Argentina), UPL France, UPL Italia SRL, UPL South Africa PTY Ltd and UPL do Brasil Industria e Comercio de SA (Brazil). The company has manufacturing units in India, France, Argentina, the UK, Vietnam, Turkey, Brazil, the USA, China, Thailand, Italy, Australia, and Columbia.

Key Financial Indicators

Particulars for year ending March 31

Unit

2022

2021

Revenue

Rs crore

46,240

38,656

Adjusted profit after tax (PAT)^

Rs crore

3,327

2,385

PAT margin^

%

7.2

6.2

Adjusted debt/Adjusted net worth ^

Times

0.99

1.12

Adjusted interest coverage

Times

4.33

4.15

^CRISIL Ratings-adjusted numbers for treatment of goodwill

Any other information: Not Applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings` complexity levels are assigned to various types of financial instruments and are included (where applicable) in the 'Annexure - Details of Instrument' in this Rating Rationale.

CRISIL Ratings will disclose complexity level for all securities - including those that are yet to be placed - based on available information. The complexity level for instruments may be updated, where required, in the rating rationale published subsequent to the issuance of the instrument when details on such features are available.

For more details on the CRISIL Ratings` complexity levels please visit www.crisil.com/complexity-levels. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of

 instrument

Date of allotment

Coupon
rate (%)

Maturity

date

Issue size
(Rs crore)

Complexity level

Rating assigned

with outlook

NA

Cash Credit#

NA

NA

NA

1029

NA

CRISIL AA+/Stable

NA

Letter of credit & Bank Guarantee

NA

NA

NA

597

NA

CRISIL A1+

NA

Fund-Based Facilities*

NA

NA

NA

1666

NA

CRISIL AA+/Stable

NA

Proposed Working Capital Facility**

NA

NA

NA

3108

NA

CRISIL AA+/Stable

NA

Commercial paper

NA

NA

7-365 days

1500

Simple

CRISIL A1+

NA

Commercial paper

NA

NA

7-365 days

300

Simple

CRISIL A1+

#Fully interchangeable between cash credit, working capital demand loan, foreign currency non-resident (Bank) loans, packing credit in INR, packing credit in foreign currency, export bill discounting in INR and foreign currency, buyer's credit for imports and domestic purchases, and domestic sales bill discounting. It can also be converted into non-fund-based facilities.

*Fully interchangebale with Non-fund based facilities

** It can be converted into non-fund-based facilities.

Annexure – List of entities consolidated

Names of 

Entities Consolidated

Extent of

Consolidation

Rationale for Consolidation

UPL Global Business Services Limited (FKA Shroffs United Chemicals Limited)

Full

Wholly owned subsidiary

SWAL Corporation Limited

Full

Wholly owned subsidiary

United Phosphorus (India) LLP

Full

Wholly owned subsidiary

United Phosphorus Global LLP

Full

Wholly owned subsidiary

UPL Sustainable Agri Solutions Limited  (FKA Optima Farm Solutions Ltd)

Full

Wholly owned subsidiary

UPL Europe Limited

Full

Subsidiary

United Phosphorus Polska Sp.z o.o - Poland

Full

Subsidiary

UPL Benelux B.V.

Full

Subsidiary

Cerexagri B.V.

Full

Subsidiary

UPL Holdings Cooperatief U.A (FKA United Phosphorus Holdings Cooperatief U.A.)

Full

Subsidiary

UPL Holdings BV  (FKA United Phosphorus Holdings B.V., Netherlands)

Full

Subsidiary

Decco Worldwide Post-Harvest Holdings Cooperatief U.A.

Full

Subsidiary

Decco Worldwide Post-Harvest Holdings B.V.

Full

Subsidiary

UPL Holdings Brazil B.V. (FKA United Phosphorus Holding, Brazil B.V. )

Full

Subsidiary

UPL Italia S.R.L.

Full

Subsidiary

UPL Iberia, S.A.

Full

Subsidiary

Decco Iberica Postcosecha, S.A.U.

Full

Subsidiary

Transterra Invest, S. L. U.

Full

Subsidiary

Cerexagri S.A.S.

Full

Subsidiary

UPL France

Full

Subsidiary

UPL Switzerland AG  (Formerly Known as United Phosphorus Switzerland Limited)

Full

Subsidiary

Decco Italia SRL

Full

Subsidiary

Limited Liability Company "UPL"

Full

Subsidiary

Decco Portugal Post Harvest LDA (formerly known as UPL Portugal Unipessoal LDA)

Full

Subsidiary

UPL NA Inc. (formerly known as United Phosphorus Inc.)

Full

Subsidiary

Cerexagri, Inc. (PA)

Full

Subsidiary

UPL Delaware, Inc.

Full

Subsidiary

Decco US Post-Harvest Inc

Full

Subsidiary

RiceCo LLC

Full

Subsidiary

Riceco International, Inc.

Full

Subsidiary

UPL Corporation Limited

Full

Subsidiary

UPL Management DMCC

Full

Subsidiary

UPL Limited

Full

Subsidiary

UPL Agro S.A. de C.V.

Full

Subsidiary

Decco PostHarvest Mexico (Formerly Known as Decco Jifkins Mexico Sapi)

Full

Subsidiary

Uniphos Industria e Comercio de Produtos Quimicos Ltda.

Full

Subsidiary

Upl do Brasil Industria e Comércio de Insumos Agropecuários S.A.

Full

Subsidiary

UPL Costa Rica S.A.

Full

Subsidiary

UPL Bolivia S.R.L

Full

Subsidiary

UPL Paraguay S.A.

Full

Subsidiary

UPL SL Argentina S.A. (Formerly Known as Icona Sanluis  S A)

Full

Subsidiary

UPL Argentina S A

Full

Subsidiary

Decco Chile SpA

Full

Subsidiary

UPL Colombia SAS

Full

Subsidiary

United Phosphorus Cayman Limited

Full

Subsidiary

UP Aviation Limited

Full

Subsidiary

UPL Australia Pty Limited (Formerly known as UPL Austarlia Limited)

Full

Subsidiary

UPL Shanghai Limited

Full

Subsidiary

PT.UPL Indonesia

Full

Subsidiary

PT Catur Agrodaya Mandiri

Full

Subsidiary

UPL Limited,Hong Kong( Formerly Known as United Phosphorus Limited, Hongkong)

Full

Subsidiary

UPL Philippines Inc.

Full

Subsidiary

UPL Vietnam Co. Limited

Full

Subsidiary

UPL Japan GK (Formerly Known as UPL Limited, Japan)

Full

Subsidiary

Anning Decco Fine Chemical Co. Limited

Full

Subsidiary

UPL Ziraat Ve Kimya Sanayi Ve Ticaret Limited Sirketi

Full

Subsidiary

UPL Agromed Tohumculuk Sa,Turkey

Full

Subsidiary

Decco Israel Ltd (Formerly Known as Safepack Products Limited)

Full

Subsidiary

Citrashine (Pty) Ltd

Full

Subsidiary

Prolong Limited

Full

Subsidiary

Perrey Participações S.A

Full

Subsidiary

Advanta Netherlands Holding B.V.

Full

Subsidiary

Advanta Semillas SAIC

Full

Subsidiary

Advanta Holdings B.V.

Full

Subsidiary

Advanta Seeds International

Full

Subsidiary

Pacific Seeds Holdings (Thailand) Limited

Full

Subsidiary

Pacific Seeds (Thai) Limited

Full

Subsidiary

Advanta Seeds Pty Ltd

Full

Subsidiary

Advanta US LLC (formerly known as Advanta U.S. Inc.)

Full

Subsidiary

Advanta Comercio De Sementes LTDA.

Full

Subsidiary

PT Advanta Seeds Indonesia

Full

Subsidiary

Advanta Seeds DMCC

Full

Subsidiary

UPL Limited Mauritius (Formely known as UPL Agro Limited Mauritius)

Full

Subsidiary

UPL Jiangsu Limited

Full

Subsidiary

Riceco International Bangladesh Ltd

Full

Subsidiary

Uniphos Malaysia Sdn Bhd

Full

Subsidiary

Advanta Seeds Ukraine LLC

Full

Subsidiary

Decco Gida Tarim ve Zirai Ürünler San. Tic A.S.

Full

Subsidiary

Arysta LifeScience America Inc.

Full

Subsidiary

Arysta LifeScience Management Company, LLC

Full

Subsidiary

Arysta LifeScience India Limited

Full

Subsidiary

Arysta LifeScience Agriservice Private Limited

Full

Subsidiary

UPL Togo SAU (FKA Arysta LifeScience Togo SAU)

Full

Subsidiary

Arysta Agro Private Limited

Full

Subsidiary

GBM USA LLC

Full

Subsidiary

UPL Agrosolutions Canada Inc (Formerly Known as Arysta LifeScience Canada, Inc.)

Full

Subsidiary

Arysta LifeScience North America, LLC

Full

Subsidiary

Arysta LifeScience NA Holding LLC

Full

Subsidiary

Arysta LifeScience Inc.

Full

Subsidiary

Arysta LifeScience Services LLP

Full

Subsidiary

Arysta LifeScience Benelux SPRL

Full

Subsidiary

Arysta LifeScience (Mauritius) Ltd

Full

Subsidiary

UPL South Africa (Pty) Ltd ( Formerly Known as Arysta LifeScience South Africa (Pty) Ltd)

Full

Subsidiary

Arysta Health and Nutrition Sciences Corporation

Full

Subsidiary

Arysta LifeScience Corporation

Full

Subsidiary

Arysta LifeScience S.A.S.

Full

Subsidiary

Arysta LifeScience Chile S.A.

Full

Subsidiary

Arysta LifeScience Mexico, S.A.de C.V

Full

Subsidiary

Grupo Bioquimico Mexicano, S.A. de C.V.

Full

Subsidiary

Arysta LifeScience UK & Ireland Ltd

Full

Subsidiary

UPL Agricultural Solutions (Formerly Known as  MacDermid Agricultural Solutions Italy Srl)

Full

Subsidiary

UPL Europe Supply Chain GmbH (Formerly Known as  Platform Sales Suisse GmbH)

Full

Subsidiary

UPL Agricultural Solutions Holdings BV (Formerly Known as MacDermid Agricultural Solutions Holdings BV)

Full

Subsidiary

Netherlands Agricultural Investment Partners LLC

Full

Subsidiary

UPL Bulgaria EOOD (FKA Arysta LifeScience Bulgaria EOOD)

Full

Subsidiary

UPL Agricultural Solutions Romania SRL  (FKA Arysta LifeScience Romania SRL)

Full

Subsidiary

Arysta LifeScience Great Britain Ltd

Full

Subsidiary

Arysta LifeScience Netherlands BV

Full

Subsidiary

Arysta LifeScience RUS LLC

Full

Subsidiary

Arysta LifeScience Australia Pty Ltd.

Full

Subsidiary

Arysta-LifeScience Ecuador S.A.

Full

Subsidiary

Arysta LifeScience Ougrée Production Sprl

Full

Subsidiary

UPL Hellas S.A. (Formerly Known as Arysta LifeScience Hellas S.A. Plant Protection, Nutrition and Other Related Products and Services)

Full

Subsidiary

Naturagri Soluciones, SLU (Formerly known as Arysta LifeScience Iberia SLU)

Full

Subsidiary

Arysta LifeScience Switzerland Sarl

Full

Subsidiary

Vetophama SAS (Formerly known as Arysta Animal Health SAS)

Full

Subsidiary

Sci PPWJ

Full

Subsidiary

Vetopharma Iberica SL (Formerly known as Santamix Iberica SL,Spain)

Full

Subsidiary

United Phosphorus  Global Services Limited (FKA Arysta LifeScience Global Services Limited)

Full

Subsidiary

Arysta LifeScience European Investments Limited

Full

Subsidiary

Arysta LifeScience U.K. Limited

Full

Subsidiary

Arysta LifeScience U.K. CAD Limited

Full

Subsidiary

Arysta LifeScience U.K. EUR Limited

Full

Subsidiary

Arysta LifeScience U.K. JPY Limited

Full

Subsidiary

Arysta LifeScience U.K. USD Limited

Full

Subsidiary

Arysta Lifescience U.K. Holdings Limited

Full

Subsidiary

Arysta LifeScience Japan Holdings Goudou Kaisha

Full

Subsidiary

Arysta LifeScience Cameroun SA

Full

Subsidiary

Callivoire SGFD S.A.

Full

Subsidiary

UPL Egypt Ltd (Formerly Known as Arysta LifeScience Egypt Ltd)

Full

Subsidiary

Calli Ghana Ltd.

Full

Subsidiary

Arysta LifeScience Kenya Ltd.

Full

Subsidiary

Mali Protection Des Cultures (M.P.C.) SA

Full

Subsidiary

Agrifocus Limitada

Full

Subsidiary

UPL Holdings SA (Pty) Ltd (FKA Arysta LifeScience Holdings SA (Pty) Ltd)

Full

Subsidiary

Anchorprops 39 (Pty) Ltd

Full

Subsidiary

Sidewalk Trading (Pty) Ltd

Full

Subsidiary

Volcano Agroscience (Pty) Ltd

Full

Subsidiary

UPL (T) Ltd (Formerly Known as Arysta LifeScience Tanzania Ltd)

Full

Subsidiary

Pt. Arysta LifeScience Tirta Indonesia

Full

Subsidiary

UPL Limited Korea (FKA Arysta LifeScience Korea Ltd.)

Full

Subsidiary

Arysta LifeScience Pakistan (Pvt.) LTD.

Full

Subsidiary

Arysta LifeScience Philippines Inc.

Full

Subsidiary

Arysta LifeScience Asia Pte., Ltd.

Full

Subsidiary

Arysta LifeScience (Thailand) Co., Ltd.

Full

Subsidiary

Arysta LifeScience Vietnam Co., Ltd.

Full

Subsidiary

Laboratoires Goëmar SAS

Full

Subsidiary

UPL Czech s.r.o. (FKA Arysta LifeScience Czech s.r.o.)

Full

Subsidiary

UPL Deutschland GmbH, (formerly known as Arysta LifeScience Germany GmbH)

Full

Subsidiary

UPL Hungary Kereskedelmi és Szolgáltató Korlátolt Felelosségu Társaság. (FKA Arysta LifeScience Magyarorszag Kft.)

Full

Subsidiary

UPL Polska Sp. z.o.o ( formerly known as Arysta LifeScience Polska Sp. z.o.o)

Full

Subsidiary

Betel Reunion S.A.

Full

Subsidiary

Arysta LifeScience Vostok Ltd.

Full

Subsidiary

UPL Slovakia S.R.O ( FKA Arysta LifeScience Slovakia S.R.O.)

Full

Subsidiary

UPL Ukraine LLC (FKA Arysta LifeScience Ukraine LLC)

Full

Subsidiary

UPL Global Limited  (Formerly Known as Arysta LifeScience Global Limited)

Full

Subsidiary

Arysta LifeScience Colombia S.A.S

Full

Subsidiary

Arysta LifeScience CentroAmerica, S.A.

Full

Subsidiary

Desarrollos Inmobiliarios Alianza de Coahuila, S.A. de C.V.

Full

Subsidiary

Omega Agroindustrial, S.A. de C.V.

Full

Subsidiary

Servicios Agricolas Mundiales SA de CV

Full

Subsidiary

Arysta LifeScience Paraguay S.R.L.

Full

Subsidiary

Arysta LifeScience Peru S.A.C

Full

Subsidiary

Arysta LifeScience Costa Rica SA.

Full

Subsidiary

Arysta LifeScience de Guatemala, S.A.

Full

Subsidiary

Arysta LifeScience S.R.L.

Full

Subsidiary

Myanmar Arysta LifeScience Co., Ltd.

Full

Subsidiary

Arysta LifeScience U.K. BRL Limited

Full

Subsidiary

UPL New Zealand Limited ( FKA Etec Crop Solutions Limited)

Full

Subsidiary

MacDermid Agricultural Solutions Australia Pty Ltd

Full

Subsidiary

Arysta LifeScience Registrations Great Britain Ltd

Full

Subsidiary

Industrias Agriphar SA

Full

Subsidiary

Agripraza Ltda.

Full

Subsidiary

Arysta LifeScience Corporation Republica Dominicana, SRL

Full

Subsidiary

Grupo Bioquimico Mexicano Republica Dominicana SA

Full

Subsidiary

Arvesta Paraguay S.A.

Full

Subsidiary

Arysta Agroquimicos y Fertilzantes Uruguay SA

Full

Subsidiary

Arysta LifeScience U.K. USD-2 Limited

Full

Subsidiary

Industrias Bioquim Centroamericana, Sociedad Anónima

Full

Subsidiary

Bioquim Panama, Sociedad Anónima

Full

Subsidiary

UPL Nicaragua, Sociedad Anónima (FKA Bioquim Nicaragua, Sociedad Anónima)

Full

Subsidiary

Biochemisch Dominicana, Sociedad De Responsabilidad Limitada

Full

Subsidiary

Nutriquim De Guatemala, Sociedad Anónima

Full

Subsidiary

UPL Agro Ltd

Full

Subsidiary

UPL Portugal Unipessoal, Ltda.

Full

Subsidiary

UPL Services LLC

Full

Subsidiary

United Phosphorus Holdings Uk Ltd

Full

Subsidiary

Nurture Agtech Pvt Ltd. (FKA AFS Agtech Pvt. Limited)

Full

Wholly owned subsidiary

Natural Plant Protection Limited

Full

Subsidiary

Advanta Biotech General Trading Ltd

Full

Subsidiary

UPL Mauritius Limited

Full

Subsidiary

Hannaford Nurture Farm Exchange Pty Ltd

Full

Subsidiary

UPL Zambia Ltd

Full

Subsidiary

INGEAGRO S.A

Full

Subsidiary

Laoting Yoloo Bio-Technology Co. Ltd

Full

Subsidiary

Decco Holdings UK Ltd

Full

Subsidiary

Advanta Seeds Holdings UK Ltd

Full

Subsidiary

Advanta Holdings US Inc.

Full

Subsidiary

UPL Crop Protection Investments UK Limited

Full

Subsidiary

UBDS COMERCIO DE PRODUTOS AGROPECUARIOS S.A

Full

Subsidiary

UPL Investments Southern Africa Pty Ltd

Full

Subsidiary

UPL Ltd , Cayman

Full

Subsidiary

UPL Health & Nutrition Science Holdings Limited

Full

Subsidiary

UPL Animal Health Holdings Limited

Full

Subsidiary

UPL Investments UK Limited

Full

Subsidiary

PT Excel Meg Indo

Full

Subsidiary

PT Ace Bio Care

Full

Subsidiary

Annexure - Rating History for last 3 Years
  Current 2022 (History) 2021  2020  2019  Start of 2019
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities LT 5803.0 CRISIL AA+/Stable 15-06-22 CRISIL AA+/Stable 21-12-21 CRISIL AA+/Stable 10-07-20 CRISIL AA+/Negative 30-12-19 CRISIL AA+/Negative CRISIL AA+/Watch Negative
      --   -- 03-12-21 CRISIL AA+/Stable   -- 09-09-19 CRISIL AA+/Negative --
      --   -- 28-07-21 CRISIL AA+/Stable   -- 02-01-19 CRISIL AA+/Negative --
Non-Fund Based Facilities ST 597.0 CRISIL A1+ 15-06-22 CRISIL A1+ 21-12-21 CRISIL A1+ 10-07-20 CRISIL A1+ 30-12-19 CRISIL A1+ CRISIL A1+
      --   -- 03-12-21 CRISIL A1+   -- 09-09-19 CRISIL A1+ --
      --   -- 28-07-21 CRISIL A1+   -- 02-01-19 CRISIL A1+ --
Commercial Paper ST 1800.0 CRISIL A1+ 15-06-22 CRISIL A1+ 21-12-21 CRISIL A1+ 10-07-20 CRISIL A1+ 30-12-19 CRISIL A1+ CRISIL A1+
      --   -- 03-12-21 CRISIL A1+   -- 09-09-19 CRISIL A1+ --
      --   -- 28-07-21 CRISIL A1+   -- 02-01-19 CRISIL A1+ --
Non Convertible Debentures LT   --   -- 28-07-21 Withdrawn 10-07-20 CRISIL AA+/Negative 30-12-19 CRISIL AA+/Negative CRISIL AA+/Watch Negative
      --   --   --   -- 09-09-19 CRISIL AA+/Negative --
      --   --   --   -- 02-01-19 CRISIL AA+/Negative --
All amounts are in Rs.Cr.
Annexure - Details of Bank Lenders & Facilities
Facility Amount (Rs.Crore) Name of Lender Rating
Cash Credit& 243 State Bank of India CRISIL AA+/Stable
Cash Credit& 100 Canara Bank CRISIL AA+/Stable
Cash Credit& 97 Union Bank of India CRISIL AA+/Stable
Cash Credit& 50 ICICI Bank Limited CRISIL AA+/Stable
Cash Credit& 68 IDBI Bank Limited CRISIL AA+/Stable
Cash Credit& 75 Axis Bank Limited CRISIL AA+/Stable
Cash Credit& 114 Kotak Mahindra Bank Limited CRISIL AA+/Stable
Cash Credit& 282 Bank of Baroda CRISIL AA+/Stable
Fund-Based Facilities< 740 JP Morgan Chase Bank N.A. CRISIL AA+/Stable
Fund-Based Facilities< 926 MUFG Bank CRISIL AA+/Stable
Letter of credit & Bank Guarantee 97 IDBI Bank Limited CRISIL A1+
Letter of credit & Bank Guarantee 129 Bank of Baroda CRISIL A1+
Letter of credit & Bank Guarantee 39 Kotak Mahindra Bank Limited CRISIL A1+
Letter of credit & Bank Guarantee 23 Canara Bank CRISIL A1+
Letter of credit & Bank Guarantee 122 State Bank of India CRISIL A1+
Letter of credit & Bank Guarantee 43 Union Bank of India CRISIL A1+
Letter of credit & Bank Guarantee 75 ICICI Bank Limited CRISIL A1+
Letter of credit & Bank Guarantee 69 Axis Bank Limited CRISIL A1+
Proposed Working Capital Facility&& 3108 Not Applicable CRISIL AA+/Stable
This Annexure has been updated on 19-Dec-22 in line with the lender-wise facility details as on 03-Dec-21 received from the rated entity
& - Fully interchangeable between cash credit, working capital demand loan, foreign currency non-resident (Bank) loans, packing credit in INR, packing credit in foreign currency, export bill discounting in INR and foreign currency, buyer's credit for imports and domestic purchases, and domestic sales bill discounting. It can also be converted into non-fund-based facilities.
< - Fully interchangeable with non-fund-based facilities
&& - It can be converted into non-fund-based facilities.
Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating Criteria for Chemical Industry
CRISILs Criteria for rating short term debt
CRISILs Criteria for Consolidation

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Anuj Sethi
Senior Director
CRISIL Ratings Limited
D:+91 44 6656 3100
anuj.sethi@crisil.com


Poonam Upadhyay
Director
CRISIL Ratings Limited
D:+91 22 3342 3386
poonam.upadhyay@crisil.com


Sudhanshu Cyril
Manager
CRISIL Ratings Limited
B:+91 44 6656 3100
Sudhanshu.Cyril@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 

 



About CRISIL Limited

CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks and leading corporations.

CRISIL is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.


For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL's privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale ('report') that is provided by CRISIL Ratings Limited ('CRISIL Ratings'). To avoid doubt, the term 'report' includes the information, ratings and other content forming part of the report. The report is intended for the jurisdiction of India only. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. In preparing our report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. The rating contained in the report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way. CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains.

Neither CRISIL Ratings nor its affiliates, third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively, 'CRISIL Ratings Parties') guarantee the accuracy, completeness or adequacy of the report, and no CRISIL Ratings Party shall have any liability for any errors, omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the report. EACH CRISIL RATINGS PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any), are made available on its website, www.crisilratings.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee - more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and/or relies on in its reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For details please refer to:
https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public website, www.crisilratings.com. For latest rating information on any instrument of any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301.

This report should not be reproduced or redistributed to any other person or in any form without prior written consent from CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings is a wholly owned subsidiary of CRISIL Limited.

 

 

CRISIL Ratings uses the prefix 'PP-MLD' for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisil.com/en/home/our-businesses/ratings/credit-ratings-scale.html